跳至主要内容
临床试验/NCT01491750
NCT01491750已完成2 期

Factors Affecting Guided Imagery Response in Total Knee Replacement

Kent State University2 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
82
试验地点
2
主要终点
function

研究概览

简要总结

The purpose of this mixed methods pilot study is to produce preliminary data for a randomized, placebo-controlled trial testing a biobehavioral model of the effects of guided imagery on outcomes of total knee replacement surgery.

详细描述

The study uses a mixed-method design (quantitative experimental pilot study with qualitative descriptive and multiple case study methods) to address the study aims:

AIM 1: Generate estimates of effect sizes and assess feasibility of procedures for a future RCT testing a model of a standardized, prerecorded guided imagery intervention on functional outcomes of TKR.

AIM 2: Elucidate the GI responder mechanism through analysis of the effect of imaging ability and other potential moderators on guided imagery's effects on TKR outcomes.

AIM 3: Analyze the effect of guided imagery on outcome expectancy, psychological distress, rehabilitation commitment and neuroimmune activation as mediators on TKR functional outcomes.

AIM 4: Identify patients' perspectives related to receiving, and participating in a study of, guided imagery intervention for total knee replacement surgery (TKR).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • scheduled for a single TKR
  • attendance at the hospital joint replacement class
  • ability to speak, read, and write English -

排除标准

  • current or planned use of guided imagery
  • history of previous total joint replacement
  • current enrollment in another clinical studY
  • current treatment in a pain management program
  • current diagnosis of immune disorders (e.g., rheumatoid arthritis, organ transplant, cancer, HIV, SLE)
  • use of immune altering medications in past month
  • comorbidities that would limit participation in study procedures or postoperative rehabilitation and/or impair recovery (e.g., psychosis; sensory, cognitive, neurologic or motor impairment
  • vision or hearing deficits
  • lymphedema
  • morbid obesity [BMI > 40])
  • reported diagnosis of anemia

结局指标

主要结局

function

时间窗: 6 months

WOMAC AND SF-36

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ANN F JACOBSON

Professor, College of Nursing

Kent State University

研究点 (2)

Loading locations...

相似试验